Ontogeny of hippocampal corticosteroid receptors: Effects of antenatal glucocorticoids in human and mouse
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Women at risk for preterm delivery are treated with synthetic glucocorticoids (GCs) to enhance fetal lung maturation. GCs can bind to two intracellular receptors, the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR), which function as transcription factors. Both are highly expressed in the hippocampus. Several studies have focused on adverse side effects of antenatal GC treatment. However, relatively little is known about the ontogeny of GR and MR, especially in human. Therefore, we studied the ontogeny of both receptors in the human and mouse hippocampus and investigated the effects of antenatal dexamethasone (dex) treatment, a synthetic glucocorticoid, on MR and GR mRNA levels during hippocampal development. The results demonstrate that MR mRNA was first expressed in mouse hippocampus at embryonic day (E)15.5, at the timepoint when dex was administered. In contrast, GR mRNA expression was first observed after birth at postnatal day (P)5. However, in the human hippocampus both receptors are expressed at 24 weeks of gestation, when antenatal GCs are administered in clinical practice. Quantitative in situ hybridization demonstrated that MR mRNA levels were reduced only shortly after dex treatment at E16, but were unaffected from E18 onwards. These findings indicate that a single antenatal dex administration at E15.5 transiently affects MR mRNA levels in the mouse hippocampus. No effect of antenatal dex treatment was found on the human hippocampus at the third trimester of pregnancy. These data on the prenatal ontogeny of both corticosteroid receptors in the human hippocampus is important for understanding the significance of fetal glucocorticoid or stress exposure and its potential effects on health and disease. J. Comp. Neurol. 499:924–932, 2006. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, D., Diorio, J., Tannenbaum, B., Caldji, C., Francis, D., Freedman, A., Sharma, S., Pearson, D., Plotsky, P. M., & Meaney, M. J. (1997) · Science · doi:10.1126/science.277.5332.1659 · Cited by 3,170 · cited 2×
“Programming of the HPA axis is thought to occur at the level of the hippocampus (Bakker et al., 1995; Liu et al., 1997; Matthews, 2000; Jacobson, 2005).”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
JACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Sánchez, M. M., Young, L. J., Plotsky, P. M., & Insel, T. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04657.2000 · Cited by 420
Hypothalamic-pituitary-adrenocortical axis regulation
Jacobson, L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.003 · Cited by 248 · cited 3×
“Programming of the HPA axis is thought to occur at the level of the hippocampus (Bakker et al., 1995; Liu et al., 1997; Matthews, 2000; Jacobson, 2005).”
Background
Cited by
The long-term behavioural consequences of prenatal stress
Weinstock, M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.002 · Cited by 1,052
Glucocorticoids, prenatal stress and the programming of disease
Harris, A., & Seckl, J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.06.007 · Cited by 871
Glucocorticoids and fetal programming part 1: outcomes
Moisiadis, V. G., & Matthews, S. G. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.73 · Cited by 576
Modulation of the Hypothalamic-Pituitary-Adrenal Axis by Early Life Stress Exposure
van Bodegom, M., Homberg, J. R., & Henckens, M. J. A. G. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00087 · Cited by 562
Prenatal maternal stress programs infant stress regulation
Davis, E. P., Glynn, L. M., Waffarn, F., & Sandman, C. A. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02314.x · Cited by 472
“There is evidence that both types of cortisol receptors are present in the human hippocampus by 24 gestational weeks (Noorlander, De Graan, Middeldorp, Van Beers, & Visser, 2006) indicating that in the latter half of gestation this region is susceptible to the consequences of excess cortisol.”
Epidemiology-driven neurodevelopmental animal models of schizophrenia
Meyer, U., & Feldon, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.018 · Cited by 372
Sandman, C. A., Davis, E. P., Buss, C., & Glynn, L. M. (2012) · Neuroendocrinology · doi:10.1159/000327017 · Cited by 295
Glucocorticoids, developmental ‘programming’ and the risk of affective dysfunction
Seckl, J. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)67002-2 · Cited by 245
Zijlmans, M. A. C., Riksen-Walraven, J. M., & de Weerth, C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.015 · Cited by 221
Role of the hypothalamic–pituitary–adrenal axis in developmental programming of health and disease
Xiong, F., & Zhang, L. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.11.002 · Cited by 177
Glucocorticoid receptor protein expression in human hippocampus; stability with age
Wang, Q., Van Heerikhuize, J., Aronica, E., Kawata, M., Seress, L., Joels, M., Swaab, D. F., & Lucassen, P. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.019 · Cited by 144
“Also with in situ hybridization, abundant GR mRNA was found in the human DG and CA subfields (Lopez et al., 1998; Noorlander et al., 2006; Seckl et al., 1991, 1993; Wetzel et al., 1995).”
BackgroundDavis, E. P., Waffarn, F., & Sandman, C. A. (2011) · Developmental Psychobiology · doi:10.1002/dev.20510 · Cited by 136
DeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
Humphreys, K. L., Camacho, M. C., Roth, M. C., & Estes, E. C. (2020) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2020.100877 · Cited by 67
“…cortisol can pass through the fetal blood-brain barrier and act on key signaling pathways and structures in the fetal brain (Lenniger et al., 2020; Noorlander et al., 2006) — or indirectly, by changing the amount or activity of critical neurotrophic factors, hormones, or neurotransmitters (Buss…”
BackgroundLifetime modulation of the pain system via neuroimmune and neuroendocrine interactions
Zouikr, I., & Karshikoff, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00276 · Cited by 45
“Glucocorticoid receptor (GR) mRNAs were detected in human fetal hippocampus at 24 GWs (52).”
BackgroundMacrì, S., Ceci, C., Canese, R., & Laviola, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041821 · Cited by 20
Grant, K.-A., Sandman, C. A., Wing, D. A., Dmitrieva, J., & Davis, E. P. (2015) · Psychological Science · doi:10.1177/0956797615580299 · Cited by 20
Prenatal Glucocorticoids: Short-Term Benefits and Long-Term Risks
Manojlovic-Stojanoski, M., Nestorovic, N., & Milosevic, V. (2012) · Glucocorticoids - New Recognition of Our Familiar Friend · doi:10.5772/51106 · Cited by 19
Metadata
- Authors
- Noorlander, C. W., De Graan, P. N. E., Middeldorp, J., Van Beers, J. J. B. C., & Visser, G. H. A.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2006-10-27
- Volume
- 499
- Issue
- 6
- Pages
- 924-932
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2006493242
- Cited by
- 99
- References
- 6
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.